ExploreWatchlistsPricing
  1. US-listed companies
  2. FATE THERAPEUTICS INC
  3. Financials
  4. Depreciation & amortization

FATE THERAPEUTICS INC (FATE)

Market cap
$135.27M
P/E ratio
SummaryFinancials
Period EndDepreciation & amortization (Million USD)YoY (%)
Dec 31, 202419+3.83%
Dec 31, 202318+32.61%
Dec 31, 202214+133.90%
Dec 31, 20216+90.32%
Dec 31, 20203+41.36%
Dec 31, 20192+82.14%
Dec 31, 20181+24.00%
Dec 31, 20171+10.22%
Dec 31, 20161+28.24%
Dec 31, 20151+38.51%
Dec 31, 20140-80.22%
Dec 31, 20133

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat